VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $8,208,000 | -62.0% | 41,324 | -72.6% | 0.12% | -60.3% |
| Q4 2014 | $21,617,000 | -5.7% | 151,056 | -13.6% | 0.32% | -8.2% |
| Q3 2014 | $22,932,000 | +6.3% | 174,793 | +2.2% | 0.34% | +11.7% |
| Q2 2014 | $21,569,000 | -66.3% | 171,028 | -64.8% | 0.31% | -68.2% |
| Q1 2014 | $64,053,000 | -24.8% | 485,881 | -33.0% | 0.96% | -27.3% |
| Q4 2013 | $85,135,000 | +12.1% | 725,173 | -0.3% | 1.33% | +3.7% |
| Q3 2013 | $75,917,000 | +20.7% | 727,666 | -0.4% | 1.28% | +7.5% |
| Q2 2013 | $62,914,000 | – | 730,878 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |